Hi Jaime,
Not only does the stock have to contend with tax selling (which I would judge to have already been significant, but obviously close to its conclusion), but it also has to deal with shorting against the earlier convertible debenture issue, though in my view it is unlikely to be called at thtis time.
Nevertheless, *if*, at the beginning of the year I told you that Simula's ITS would be the only side-impact head protection device meeting NHTSA's tests, that an important insurance industry testing organization had endorsed the product, and that the company felt sufficiently positive on its future that it was adding manufacturing capacity a full year prior to its actual need, what would have been your response?
The year that has gone by has not been very productive as far as the stock price is concerned, with the stock having had a veritable round trip from the bottom to the top to the bottom.
However, the business is making progress, and though one could effectively argue that there have been a few errors, there is no doubt that eventually 16G seats will be a real, profitable business, and that the ITS is well positioned for a dramatic ramp in revenues over the next 3-5 years.
All in all, not a disaster, unless you measure your investments marked to the market.
1998 will be much better. And Jaime, remember, you heard it here first. |
